Le Lézard
Classified in: Health, Science and technology, Business
Subject: JVN

AIxMed and CorePlus Partner to study a Urine Cytology Workflow Solution


Providers of digital cytology scanning and AI software to create workflow solution

SANTA CLARA, Calif. , April 18, 2024 /PRNewswire/ -- AIxMed, innovators and providers of an AI-powered computational platform for cytology applications, and CorePlus a leader in precision pathology have entered into an agreement to conduct a pilot study applying the AIxMed's AI algorithm to test a workflow solution for urine cytology.

"...an AI-powered computational platform will save time, improve accuracy, and greatly aid research..."

AIxMed's experience in cytology software and analysis, combined with CorePlus' experience in integrating digital and AI solutions into their day-to-day pathology workflow will come together to provide an end-to-end solution for research-use only urine cytology analysis.

"Both AIxMed and CorePlus have demonstrated our commitment to enhancing urine cytology workflow efficiencies utilizing the tools of digital cytology, so joining forces to demonstrate a new digital urine cytology platform together is a natural fit," said Samuel Chen, CEO of AIxMed.

Due to the shortage of cytologists and the manual nature of cell characterization, cytology needs new tools to improve workflow and provide quantitative and qualitative information. AI-powered computational tools have the potential to deliver these insights and allow a more efficient and precise process with the existing workforce.

"Being able to rapidly image slides with our in-house scanner for cytology, and then characterize cells with an AI-powered computational platform will save time, improve accuracy, and greatly aid research in the battle against bladder cancer," said Mariano de Socarraz, Founder and CEO of CorePlus.

About AIxMed
Founded in 2018, AIxMed is creating a roadmap to transforming cancer diagnosis and monitoring through our smart computational cytology platform. This solution simplifies clinical workflows and richly strengthens the quality of healthcare by aiding critical decision support during clinical diagnosis and monitoring. To learn more visit www.aixmed.com.

About CorePlus
CorePlus Servicios Clinicos y Patologicos, LLC is a privately held precision pathology company headquartered in Carolina, Puerto Rico.  CorePlus is a high complexity CLIA certified laboratory, our mission is to bring the latest advancements in medical technology and clinical procedures to evaluate, diagnose, and treat various medical conditions through the expertise of our highly specialized pathologists. The CorePlus team, comprised of pathologists and scientists, has become the first in the United States and the Americas to implement AI based tools in digital pathology for primary diagnosis. To learn more visit www.corepluspr.com.

SOURCE AIxMed, Inc.


These press releases may also interest you

at 12:20
Aubex Therapeutics Inc., a pioneering biotechnology firm, announced its official launch, heralding a new era in the battle against cancer. Under the guidance of Board Member and Interim CEO, Jeffrey Glazer, Aubex's initial program is focused on novel...

at 12:15
Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, today announced that data from its preclinical gene edited HLA-A*11:01 KRAS G12D (AFNT-212) and HLA-A*02:01 TP53 R175H T...

at 12:15
uLab Systems® announces the release of the uDesign® 9 treatment planning software, the AI-assisted platform designed exclusively for orthodontists to maximize their control over treatment and provide more aligner workflow flexibility than any other...

at 12:15
ImageTrend, LLC., the leader in innovative public safety and healthcare software solutions, is excited to announce the launch of its Fire Continuous Quality Improvement (CQI) module, a highly requested tool that will help fire services measure and...

at 12:09
Millions of people in the U.S. live with asthma, which is a life-long chronic lung disease. While we have proven asthma management techniques and treatments, people living with asthma and their healthcare providers face increasing challenges due to...

at 12:07
EverGlade Consulting is pleased to announce the appointment of Dr. Joe Larsen as Managing Director, effective April 2024. Dr. Larsen brings with him a rich background in biomedical research and healthcare policy, significantly enhancing EverGlade's...



News published on and distributed by: